Parameters affecting the efficacy of a sustained release polymeric implant of leuprolide
- 1 January 2000
- journal article
- Published by Elsevier in International Journal of Pharmaceutics
- Vol. 194 (2) , 181-191
- https://doi.org/10.1016/s0378-5173(99)00371-3
Abstract
No abstract availableKeywords
This publication has 11 references indexed in Scilit:
- Sustained suppression of pituitary‐gonadal axis with an injectable, in situ forming implant of leuprolide acetateJournal of Pharmaceutical Sciences, 2000
- Biodegradable Microspheres in Drug DeliveryCritical Reviews in Therapeutic Drug Carrier Systems, 1995
- LeuprorelinDrugs, 1994
- Sustained Pharmacological Activities in Rats Following Single and Repeated Administration of Once-a-Month Injectable Microspheres of Leuprolide AcetatePharmaceutical Research, 1991
- Pharmacokinetics of Once-a-Month Injectable Microspheres of Leuprolide AcetatePharmaceutical Research, 1991
- Clinical Study of Leuprolide Depot Formulation in the Treatment of Advanced Prostate CancerJournal of Urology, 1990
- Biodegradable Polyamides Based on 4,4′-SpirobibutyrolactonePublished by Springer Nature ,1990
- Leuprolide versus Diethylstilbestrol for Metastatic Prostate CancerNew England Journal of Medicine, 1984
- Potential new treatment of endometriosis: reversible inhibition of pituitary-ovarian function by chronic intranasal administration of a luteinizing hormone-releasing hormone (LH-RH) agonistFertility and Sterility, 1982
- Inhibition of prostate tumor growth in two rat models by chronic administration of D-Trp6 analogue of luteinizing hormone-releasing hormone.Proceedings of the National Academy of Sciences, 1981